Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis

被引:164
作者
Jiang, Shan [1 ,2 ]
Yan, Cheng [3 ]
Fang, Qi-chen [1 ,2 ]
Shao, Meng-le [3 ]
Zhang, Yong-liang [3 ]
Liu, Yang [3 ]
Deng, Yi-ping [3 ]
Shan, Bo [3 ]
Liu, Jing-qi [3 ]
Li, Hua-ting [1 ,2 ]
Yang, Liu [3 ]
Zhou, Jian [4 ]
Dai, Zhi [4 ]
Liu, Yong [3 ]
Jia, Wei-ping [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai Key Lab Diabet Mellitus,Dept Endocrinol, Shanghai 200233, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis, Shanghai 200233, Peoples R China
[3] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
ER Stress; Fibroblast Growth Factor (FGF); Hepatocyte; Liver Metabolism; Unfolded Protein Response (UPR); FATTY LIVER-DISEASE; ER STRESS; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; PPAR-ALPHA; METABOLIC REGULATOR; ENERGY-EXPENDITURE; MESSENGER-RNA; BETA-KLOTHO; FGF21;
D O I
10.1074/jbc.M114.565960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Although both are involved in metabolic homeostasis, the interconnection between ER stress and FGF21 remains incompletely understood. Results: Directly up-regulated by the IRE1-XBP1 pathway, FGF21 could alleviate ER stress-induced liver steatosis. Conclusion: FGF21 acts as a metabolic effector of the UPR program, exerting feedback effects upon lipid metabolism. Significance: These findings reveal a regulatory mechanism linking FGF21 actions to metabolic ER stress. Endoplasmic reticulum (ER) stress activates the adaptive unfolded protein response (UPR) and represents a critical mechanism that underlies metabolic dysfunctions. Fibroblast growth factor 21 (FGF21), a hormone that is predominantly secreted by the liver, exerts a broad range of effects upon the metabolism of carbohydrates and lipids. Although increased circulating levels of FGF21 have been documented in animal models and human subjects with obesity and nonalcoholic fatty liver disease, the functional interconnections between metabolic ER stress and FGF21 are incompletely understood. Here, we report that increased ER stress along with the simultaneous elevation of FGF21 expression were associated with the occurrence of nonalcoholic fatty liver disease both in diet-induced obese mice and human patients. Intraperitoneal administration of the ER stressor tunicamycin in mice resulted in hepatic steatosis, accompanied by activation of the three canonical UPR branches and increased the expression of FGF21. Furthermore, the IRE1-XBP1 pathway of the UPR could directly activate the transcriptional expression of Fgf21. Administration of recombinant FGF21 in mice alleviated tunicamycin-induced liver steatosis, in parallel with reduced eIF2-ATF4-CHOP signaling. Taken together, these results suggest that FGF21 is an integral physiological component of the cellular UPR program, which exerts beneficial feedback effects upon lipid metabolism through counteracting ER stress.
引用
收藏
页码:29751 / 29765
页数:15
相关论文
共 58 条
[1]  
Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
[2]   Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].
Bedogni, G ;
Miglioli, L ;
Masutti, F ;
Tiribelli, C ;
Marchesini, G ;
Bellentani, S .
HEPATOLOGY, 2005, 42 (01) :44-52
[3]   Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance [J].
Chavez, Alberto O. ;
Molina-Carrion, Marjorie ;
Abdul-Ghani, Muhammad A. ;
Folli, Franco ;
DeFronzo, Ralph A. ;
Tripathy, Devjit .
DIABETES CARE, 2009, 32 (08) :1542-1546
[4]   Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines [J].
Chitturi, Shivakumar ;
Farrell, Geoffrey C. ;
Hashimoto, Etsuko ;
Saibara, Toshiji ;
Lau, George K. K. ;
Sollano, Jose D. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) :778-787
[5]   Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man [J].
Christodoulides, Constantinos ;
Dyson, Pamela ;
Sprecher, Dennis ;
Tsintzas, Kostas ;
Karpe, Fredrik .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3594-3601
[6]   Fibroblast Growth Factor 21 Corrects Obesity in Mice [J].
Coskun, Tamer ;
Bina, Holly A. ;
Schneider, Michael A. ;
Dunbar, James D. ;
Hu, Charlie C. ;
Chen, Yanyun ;
Moller, David E. ;
Kharitonenkov, Alexei .
ENDOCRINOLOGY, 2008, 149 (12) :6018-6027
[7]   TRANSCRIPTIONAL INDUCTION OF GENES ENCODING ENDOPLASMIC-RETICULUM RESIDENT PROTEINS REQUIRES A TRANSMEMBRANE PROTEIN-KINASE [J].
COX, JS ;
SHAMU, CE ;
WALTER, P .
CELL, 1993, 73 (06) :1197-1206
[8]   Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines [J].
Das, Swapan K. ;
Chu, Winston S. ;
Mondal, Ashis K. ;
Sharma, Neeraj K. ;
Kern, Philip A. ;
Rasouli, Neda ;
Elbein, Steven C. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (02) :E393-E400
[9]   Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones [J].
Dutchak, Paul A. ;
Katafuchi, Takeshi ;
Bookout, Angie L. ;
Choi, Jang Hyun ;
Yu, Ruth T. ;
Mangelsdorf, David J. ;
Kliewer, Steven A. .
CELL, 2012, 148 (03) :556-567
[10]   The role for endoplasmic reticulum stress in diabetes mellitus [J].
Eizirik, Decio L. ;
Cardozo, Alessandra K. ;
Cnop, Miriam .
ENDOCRINE REVIEWS, 2008, 29 (01) :42-61